Stuart A. Arbuckle, EVP, Chief Comm & Operations Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 109 shares at $216.36 ($24K) on 2021-05-17, disclosed to the SEC on 2021-05-19.
Scheduled sale ($24k) by EVP, Chief Comm & Operations Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $215.33 | 7 | $2K | 6.4% |
| 2 | $216.36 | 86 | $19K | 78.9% |
| 3 | $217.15 | 16 | $3K | 14.7% |
| Total | $216.41 avg | 109 | $24K | 100% |
| Filing → |
| VRTX | SELL | 2024-02-23 | $3.0M | — | Filing → |
| VRTX | SELL | 2024-02-21 | $4.0M | — | Filing → |
| VRTX | SELL | 2024-02-13 | $3.6M | — | Filing → |